Technical Analysis for PKBO - Peak Bio Inc
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | N/A | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Stochastic Sell Signal | Bearish | 0.00% | |
Volume Surge | Other | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Boomer Sell Setup | Bearish Swing Setup | -5.06% | |
Narrow Range Bar | Range Contraction | -5.06% | |
Wide Bands | Range Expansion | -5.06% | |
Overbought Stochastic | Strength | -5.06% | |
Narrow Range Bar | Range Contraction | -5.06% | |
Wide Bands | Range Expansion | -5.06% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Down 5% | about 11 hours ago |
Down 3% | about 11 hours ago |
Down 1% | about 11 hours ago |
5x Volume Pace | about 11 hours ago |
3x Volume Pace | about 11 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of patients with inflammatory, cancer, and rare and specialty diseases. Its lead product candidate is PHP-303, which is in phase 2 clinical study for the treatment of alpha-1 antitrypsin deficiency and acute respiratory distress syndrome. It also develops Trop2 PH1, an antibody-drug-conjugate for solid tumors. The company was founded in 2020 and is headquartered in Palo Alto, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Biopharmaceutical Life Sciences Pharmaceutical Industry Pharmacy Solid Tumors Alpha Inflammatory Antitrypsin Deficiency Acute Respiratory Distress Syndrome Alpha 1 Antitrypsin Php 303 Rare And Specialty Diseases Treatment Of Patients With Inflammatory
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Biopharmaceutical Life Sciences Pharmaceutical Industry Pharmacy Solid Tumors Alpha Inflammatory Antitrypsin Deficiency Acute Respiratory Distress Syndrome Alpha 1 Antitrypsin Php 303 Rare And Specialty Diseases Treatment Of Patients With Inflammatory
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.75 |
52 Week Low | 0.465 |
Average Volume | 2,366 |
200-Day Moving Average | 0.0000 |
50-Day Moving Average | 0.7674 |
20-Day Moving Average | 0.8442 |
10-Day Moving Average | 0.9244 |
Average True Range | 0.1078 |
RSI (14) | 52.83 |
ADX | 48.93 |
+DI | 6.9425 |
-DI | 36.8411 |
Chandelier Exit (Long, 3 ATRs) | 0.6256 |
Chandelier Exit (Short, 3 ATRs) | 0.8494 |
Upper Bollinger Bands | 1.0977 |
Lower Bollinger Band | 0.5907 |
Percent B (%b) | 0.61 |
BandWidth | 60.0569 |
MACD Line | 0.0516 |
MACD Signal Line | 0.0448 |
MACD Histogram | 0.0068 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.9895 | ||||
Resistance 3 (R3) | 0.9957 | 0.9723 | 0.9748 | ||
Resistance 2 (R2) | 0.9723 | 0.9498 | 0.9693 | 0.9698 | |
Resistance 1 (R1) | 0.9367 | 0.9359 | 0.9250 | 0.9305 | 0.9649 |
Pivot Point | 0.9133 | 0.9133 | 0.9075 | 0.9103 | 0.9133 |
Support 1 (S1) | 0.8777 | 0.8908 | 0.8660 | 0.8715 | 0.8371 |
Support 2 (S2) | 0.8543 | 0.8769 | 0.8513 | 0.8322 | |
Support 3 (S3) | 0.8187 | 0.8543 | 0.8273 | ||
Support 4 (S4) | 0.8125 |